The mechanism of non-islet cell hypoglycaemia caused by tumour-produced IGF-II [1]

Clinical Endocrinology

Volumn 67, Issue 4, 2007, Pages 637-638

  Zachariah, S ^a   Brackenridge, A ^a   Shojaee Moradie, F ^b   Camuncho Hubner, C ^c   Umpleby, A M ^b   Russell Jones, D ^a,b  

^a ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SURREY   (United Kingdom)

^c John Vane Science Building ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; C PEPTIDE; GLUCOSE; INSULIN; SOMATOMEDIN B; SOMATOMEDIN C;

ADULT; ANAMNESIS; BODY MASS; CASE REPORT; GLUCOSE TRANSPORT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOGLYCEMIA; IMMUNOBLOTTING; INSULINOMA; LETTER; MALE; MOLECULAR WEIGHT; MORTALITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

GLUCOSE TOLERANCE TEST; HUMANS; HYPOGLYCEMIA; INSULIN-LIKE GROWTH FACTOR II; MALE; MESODERM; MIDDLE AGED; NEOPLASM PROTEINS;

EID: 34548680955     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02938.x     Document Type: Letter

References (6)

1. Teale, J.D. Wark, G. (2004) The effectiveness of different treatment options for non-islet cell tumour hypoglycaemia. Clinical Endocrinology, 60, 457 460.
2. Steele, R., Bishop, J.S., Dunn, A., Altszuler, N., Rathbeb, I. De Bodo, R.C. (1965) Inhibition by insulin of hepatic glucose production in the normal dog. American Journal of Physiology, 208, 301 306.
3. Hoog, A., Sandberg, A.C., Hulting, A.L. Falkmer, U.G. (1997) High molecular weight IGF-2 expression in a haemangiopericytoma associated with hypoglycaemia. APMIS, 105, 469 482.
4. Baxter, R. (1996) The role of insulin-like growth factors and their binding proteins in tumour hypoglycaemia. Hormone Research, 46, 195 201.
5. Holly, J.M. (1998) The IGF-II enigma. Growth Hormone & IGF Research, 8, 183 184.
6. Daughaday, W.H., Trivedi, B., Baxter, R.C. (1993) Serum 'big insulin-like growth factor-II from patients with tumour hypoglycemia lacks normal, E-domain, O-linked glycosylation, a possible determinant of normal propeptide processing. Proceedings of the National Academy of Sciences of the USA, 90, 5823 5827.